close 73% of retail accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

LLY

967.4

+4.88%↑

JNJ

187.23

+0.5%↑

UNH

322.07

-0.63%↓

NVS

126.46

+0.14%↑

ABT

125.34

-0.67%↓

LLY

967.4

+4.88%↑

JNJ

187.23

+0.5%↑

UNH

322.07

-0.63%↓

NVS

126.46

+0.14%↑

ABT

125.34

-0.67%↓

LLY

967.4

+4.88%↑

JNJ

187.23

+0.5%↑

UNH

322.07

-0.63%↓

NVS

126.46

+0.14%↑

ABT

125.34

-0.67%↓

LLY

967.4

+4.88%↑

JNJ

187.23

+0.5%↑

UNH

322.07

-0.63%↓

NVS

126.46

+0.14%↑

ABT

125.34

-0.67%↓

LLY

967.4

+4.88%↑

JNJ

187.23

+0.5%↑

UNH

322.07

-0.63%↓

NVS

126.46

+0.14%↑

ABT

125.34

-0.67%↓

Home・Stock List・Palvella Therapeutics Inc
Search

Palvella Therapeutics Inc

Open

SectorHealthcare

79.5 3.19

Strong Buy

Price update 10 Nov 2025, 16:02 UTC

BuySell

Overview

Share price change

24h

Current

Min

78.03

Max

81.42

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+46.19% upside

Dividends

By Dow Jones

Next Earnings

11 Nov 2025

News Sentiment

By Acuity

56%

44%

297 / 374 Healthcare

Palvella Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

9 Nov 2025, 21:36 UTC

Earnings

Australia's ANZ Bank Posts 10% Drop in Annual Profit -- Update

DJ

Read

9 Nov 2025, 21:22 UTC

Earnings

Australia's ANZ Bank Posts 10% Drop in Annual Profit

DJ

Read

10 Nov 2025, 00:00 UTC

Market Talk

India Inflation Poised to Hit New Low -- Market Talk

DJ

Read

9 Nov 2025, 23:47 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

DJ

Read

9 Nov 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Signs of U.S. Economic Weakness -- Market Talk

DJ

Read

9 Nov 2025, 21:05 UTC

Earnings

ANZ FY Total Operating Expenses A$12.88B Vs. A$11.465B Pro Forma>ANZ.AU

DJ

Read

9 Nov 2025, 21:04 UTC

Earnings

ANZ FY Operating Expenses A$11.85B Ex-Significant Items>ANZ.AU

DJ

Read

9 Nov 2025, 21:03 UTC

Earnings

ANZ 2H Net Interest Margin 1.54% Vs. 1.56% in 1H>ANZ.AU

DJ

Read

9 Nov 2025, 20:49 UTC

Earnings

ANZ FY Australia Retail Deposits Up 6% on Year>ANZ.AU

DJ

Read

9 Nov 2025, 20:49 UTC

Earnings

ANZ FY Australia Home Loan Lending Up 5% on Year>ANZ.AU

DJ

Read

9 Nov 2025, 20:45 UTC

Earnings

ANZ FY Average Customer Deposits A$760.8B Vs. A$669.4B>ANZ.AU

DJ

Read

9 Nov 2025, 20:45 UTC

Earnings

ANZ FY Average Gross Loans & Advances A$833.6B Vs. A$733.8B>ANZ.AU

DJ

Read

9 Nov 2025, 20:42 UTC

Earnings

ANZ FY Results Include Full-Year Benefit of Suncorp Bank Acquisition>ANZ.AU

DJ

Read

9 Nov 2025, 20:42 UTC

Earnings

ANZ FY Net Interest Margin 1.55% Vs. 1.57%>ANZ.AU

DJ

Read

9 Nov 2025, 20:41 UTC

Earnings

ANZ FY Common Equity Tier 1 Ratio 12.0% Vs. 12.2%>ANZ.AU

DJ

Read

9 Nov 2025, 20:41 UTC

Earnings

ANZ FY Net Profit Includes A$1.11B of Notable Items>ANZ.AU

DJ

Read

9 Nov 2025, 20:39 UTC

Earnings

ANZ FY Credit Impairment Charge A$441M Vs. A$406M>ANZ.AU

DJ

Read

9 Nov 2025, 20:39 UTC

Earnings

ANZ FY Rev A$22.19B Vs. A$20.55B >ANZ.AU

DJ

Read

9 Nov 2025, 20:38 UTC

Earnings

ANZ Keeps Dividend at A$0.83 >ANZ.AU

DJ

Read

9 Nov 2025, 20:38 UTC

Earnings

ANZ FY Cash Profit A$5.79B Vs. A$6.725B>ANZ.AU

DJ

Read

9 Nov 2025, 20:38 UTC

Earnings

ANZ FY Net A$5.89B Vs. Net A$6.535B >ANZ.AU

DJ

Read

8 Nov 2025, 13:10 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

DJ

Read

8 Nov 2025, 03:50 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

DJ

Read

8 Nov 2025, 03:41 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

DJ

Read

8 Nov 2025, 03:07 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

DJ

Read

7 Nov 2025, 22:36 UTC

Earnings

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

DJ

Read

7 Nov 2025, 22:22 UTC

Earnings

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

DJ

Read

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q Rev $2.95B >CSU.T

DJ

Read

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q Net $210M >CSU.T

DJ

Read

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q EPS $9.89 >CSU.T

DJ

Read

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

46.19% upside

12 Months Forecast

Average 113.78 USD  46.19%

High 200 USD

Low 70 USD

Based on 10 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

10

Buy

0

Hold

0

Sell

Based on 10 analysts giving stock ratings to Palvella Therapeutics Inc - Dist in the past 3 months.

Sentiment

By Acuity

297 / 374 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

967.4

↑ +4.88%

JNJ

Johnson and Johnson

187.23

↑ +0.5%

UNH

UnitedHealth Group Inc

322.07

↓-0.63%

NVS

Novartis AG

126.46

↑ +0.14%

ABT

Abbott Laboratories

125.34

↓-0.67%
help-icon Live chat